Skip to main content
SpringerLink
Log in

Tissue factor: A key molecule in hemostatic and nonhemostatic systems

  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Tissue factor (also known as tissue thromboplastin or CD142) is the protein that activates the blood clotting system by binding to, and activating, the plasma serine protease, factor VIIa, following vascular injury. Because of its essential role in hemo-stasis, tissue factor plays a role in pathology associated with hemostasis, triggering the coagulation system in many thrombotic diseases and the coagulopathies associated with sepsis and other forms of disseminated intravascular coagulation. Recent research has also implicated tissue factor in a variety of nonhemostatic roles, including cell signaling, inflammation, vasculo-genesis, and tumor growth and metastasis. This review focuses on both the well-known roles of tissue factor in hernostasis and thrombosis and the newer concepts of tissue-factor biology including how it functions as a signaling receptor and the possible role of blood-borne tissue factor in thrombosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues: implications for disorders of hemostasis and thrombosis.Am J Pathol. 1989;134:1087–1097.

    CAS  PubMed Central  PubMed  Google Scholar 

  2. Fleck RA, Rao LVM, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunoslaining with monospecific, poly- donal anti-human tissue factor antibody.Thromb Res. 1990.57:765–781.

    CAS  Google Scholar 

  3. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.Proc Natl Acad Sci USA. 1989;86:2839–2843.

    CAS  PubMed Central  PubMed  Google Scholar 

  4. Toomey JR, Kratzer KE, Lasky NM, Stanton JJ, Broze GJ Jr. Targeted disruption of the murine tissue factor gene results in embryonic lethality.Blood. 1996;88:1583–1587.

    CAS  PubMed  Google Scholar 

  5. Bugge TH, Xiao Q, Kombrinck KW, et al. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation.Proc Natl Acad Sci USA. 1996;93:6258–6263.

    CAS  PubMed Central  PubMed  Google Scholar 

  6. Carmeliet P, Mackman N, Moons L, et al. Role of tissue factor in embryonic blood vessel development.Nature. 1996;383:73–75.

    CAS  PubMed  Google Scholar 

  7. Rosen ED, Chan JO, Tdusogie E, et al. Mice lacking factor VII develop normally but suffer fatal perinatal bleeding.Nature. 1997; 390:290–294.

    CAS  PubMed  Google Scholar 

  8. Luther T, Mackman N. Tissue factor in the heart. Multiple roles in hemostasis, thrombosis, and inflammation.Trends Cardiovasc Med. 2001;11:307–312.

    CAS  PubMed  Google Scholar 

  9. McVey JH. Your bleeding heart: lessons from low tissue factor expression in mice.Trends Pharmacol Sci. 2003;24:269–272.

    CAS  PubMed  Google Scholar 

  10. Morrissey JH, Macik BG, Neuensch wander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation.Blood.1993;81:734–744.

    CAS  PubMed  Google Scholar 

  11. Nemerson Y, Repke D. Tissue factor accelerates the activation of coagulation factor VII: the role of a bifunctional coagulation cofactor.Thromb Res. 1985;40:351–358.

    CAS  PubMed  Google Scholar 

  12. Rao LV, Rapaport SI. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation.Proc Natl Acad Sci USA. 1988;85:6687–6691.

    CAS  PubMed Central  PubMed  Google Scholar 

  13. Radcliffe R, Nemerson Y. Activation and control of factor VII by activated factor X and thrombin: isolation and characterization of a single chain form of factor VII.J Biol Chem. 1975;250:388–395.

    CAS  PubMed  Google Scholar 

  14. Kisiel W, Fujikawa K, Davic EW. Activation of bovine factor VII (proconvrtin) by factor XIIa (activated Hageman factor).Biochemistry. 1977;16:4189–4194.

    CAS  PubMed  Google Scholar 

  15. Seligsohn U, Osterud B, Brown SF, Griffin JH, Rapaport SI. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII.J Clin Invest. 1979;64:1056.

    CAS  PubMed Central  PubMed  Google Scholar 

  16. Masys DR, Bajaj SP, Rapaport SI. Activation of human factor VII by activated factors IX and X.Blood. 1982;60:1143–1150.

    CAS  PubMed  Google Scholar 

  17. Tsujioka H, Suehiro A, Kakishita E. Activation of coagulation factor VII by tissue-type plasminogen activator.Am. J Hematol. 1999; 61:34–39.

    CAS  PubMed  Google Scholar 

  18. Nakagaki T, Foster DC, Berkner KL, Kisiel W. Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII.Biochemistry. 1991;30:10819–10824.

    CAS  PubMed  Google Scholar 

  19. Neuenschwander PF, Fiore MM, Morrissey JH. Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes. Implications of a two-dimensional enzyme kinetic mechanism.J Biol Chem. 1993;268:21489–21492.

    CAS  PubMed  Google Scholar 

  20. Romisch J. Factor VII activating protease (FSAP): a novel protease in hemostasis.Biol Chem. 2002;383:l 119–1124.

    Google Scholar 

  21. Wildgoose R Nemerson Y, Hanscn LL, Nielsen FE, Glazcr S, Hedncr U. Measurement of basal levels of factor VIIa in hemophilia A and B patients.Blood. 1992;80:25–28.

    CAS  PubMed  Google Scholar 

  22. Morrissey JH, Neuenschwander PF, Huang QL, McCallum CD, Su BX, Johnson AE. Factor VIIa tissue factor: functional importance of protein-membrane interactions.Thromb Haemost. 1997; 78:112–116.

    CAS  PubMed  Google Scholar 

  23. Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily.Proc Natl Acad Sci U S A. 1990;87:6934–6938.

    CAS  PubMed Central  PubMed  Google Scholar 

  24. Paborsky LR, Caras IW, Fisher KL, Gorman CM. Lipid association, but not the transmembrane domain, is required for tissue factor activity. Substitution of the transmembrane domain with a phosphatidylinositol anchor.J Biol Chem. 1991;266:21911–21916.

    CAS  PubMed  Google Scholar 

  25. Harlos K, Martin DMA, O’Brien DP, et al. Crystal structure of the extracellular region of human tissue factor.Nature. 1994;370:662–666.

    CAS  PubMed  Google Scholar 

  26. Muller YA, Ultsch MH, Kelley RF, De Vos AM. Structure of the extracellular domain of human tissue factor: location of the factor VIIa binding site.Biochemistry. 1994;33:10864–10870.

    CAS  PubMed  Google Scholar 

  27. Huang MD, Syed R, Stura EA, et al. The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab5G9 and TF.5G9 complex.J Mol Biol. 1998;275:873–894.

    CAS  PubMed  Google Scholar 

  28. Muller YA, Kelley RF, De Vos AM. Hinge bending within the cytokine receptor superfamily revealed by the 2.4 C crystal structure of the extracellular domain of rabbit tissue factor.Protein Sci. 1998: 7:1106–1115.

    CAS  PubMed Central  PubMed  Google Scholar 

  29. Hagen FS, Gray CL, O’Hara P, et al. Characterization of a cDNA coding for human factor VII.Proc Natl Acad Sci U S A. 1986;83:2412–2416.

    CAS  PubMed Central  PubMed  Google Scholar 

  30. O’Hara PJ, Grant FJ, Haldeman BA, et al. Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation.Proc Nad Acad Sci U S A. 1987;84:5158–5162.

    Google Scholar 

  31. Banner DW, D’Arcy A, Chene C, et al. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor.Nature. 1996;380:41–46.

    CAS  PubMed  Google Scholar 

  32. Schiodt J, Harrit N, Christensen U, Petersen LC. Two different Ca2+ ion binding sites in factor VIIa and in des(l–38) factor VIIa.FEBS Lett. 1992;306:265–268.

    CAS  PubMed  Google Scholar 

  33. Sabharwal AK, Birktoft JJ, Gorka J, Wildgoose R Petersen LC, Bajaj SP. High affinity Ca2+-binding site in the serine protease domain of human factor VIIa and its role in tissue factor binding and development of catalytic activity.J Biol Chem. 1995;270:15523–15530.

    CAS  PubMed  Google Scholar 

  34. Zhang E, St Charles R,Tulinsky A. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.J Mol Biol. 1999;285:2089–2104.

    CAS  PubMed  Google Scholar 

  35. McCallum CD, Hapak RC, Neuenschwander PF, Morrissey JH, Johnson AE. The location of the active site of blood coagulation factor VIIa above the membrane surface and its reorientation upon association with tissue factor-a fluorescence energy transfer study.J Biol Chem. 1996;271:28168–28175.

    CAS  PubMed  Google Scholar 

  36. McCallum CD, Su BX, Neuenschwander PF, Morrissey JH, Johnson AE. Tissue factor positions and maintains the factor VIIa active site far above the membrane surface even in the absence of the factor VIIa Gla domain-a fluorescence resonance energy transfer study.J Biol Chem. 1997;272:30160–30166.

    CAS  PubMed  Google Scholar 

  37. Higashi S, Nishimura H, Aita K, Iwanaga S. Identification of regions of bovine factor VII essential for binding to tissue factor.J Biol Chem. 1994;269:18891–18898.

    CAS  PubMed  Google Scholar 

  38. Higashi S, Matsumoto N, Iwanaga S. Molecular mechanism of tissue factor-mediated acceleration of factor VIIa activity.J Biol Chem. 1996;271:26569–26574.

    CAS  PubMed  Google Scholar 

  39. Chang JY, Stafford DW, Straight DL. The roles of factor VII’s structural domains in tissue factor binding.Biochemistry. 1995;34:12227–12232.

    CAS  PubMed  Google Scholar 

  40. Martin DMA, Boys CWG, Ruf W. Tissue factor: molecular recognition and cofactor function.FASEB J. 1995: 9:852–859.

    CAS  PubMed  Google Scholar 

  41. Edgington TS, Dickinson CD, Ruf W. The structural basis of function of the TF.VIIa complex in the cellular initiation of coagulation.Thromb Haemost. 1997;78:401–405.

    CAS  PubMed  Google Scholar 

  42. Higashi S, Iwanaga S. Molecular interaction between factor VII and tissue factor.lnt J Hematol. 1998;67:229–241.

    CAS  Google Scholar 

  43. Jin JP, Chang JL, Chang JY, Kelley RF, Stafford DW, Straight DL. Factor Vila’s first epidermal growth factor-like domain’s role in catalytic activity.Biochemistry. 1999;38:1185–1192.

    CAS  PubMed  Google Scholar 

  44. Eigenbrot C, Kirchhofer D. New insight into how tissue factor allosterically regulates factor VIIa.Trends Cardiovasc Med. 2002; 12:19–26.

    CAS  PubMed  Google Scholar 

  45. Eigenbrot C, Kirchhofer D, Dennis MS, et al. The factor VII zymogen structure reveals reregistration of beta strands during activation.Structure (Camb). 2001 ;9:627–636.

    CAS  Google Scholar 

  46. Maynard JR, Dreyer BE, Stemerman MB, Pitlick FA.Tissue-factor coagulant activity of cultured human endothelial and smooth muscle cells and fibroblasts.Blood. 1977;50:387–396.

    CAS  PubMed  Google Scholar 

  47. Drake TA, Ruf W, Morrissey JH, Edgington TS. Functional tissue factor is entirely cell surface expressed on LPS stimulated human blood monocytes and a constitutively tissue factor producing neo- plastic cell line.J Cell Biol. 1989;109:389–395.

    CAS  PubMed  Google Scholar 

  48. Bach R, Rifkin DB. Expression of tissue factor procoagulant activity: regulation by cytosolic calcium.Proc Natl Acad Sci U S A. 1990; 87:6995–6999.

    CAS  PubMed Central  PubMed  Google Scholar 

  49. Severs EM, Comfurius R, Dekkers DW, Harmsma M, Zwaal RF. Transmembrane phospholipid distribution in blood cells: control mechanisms and pathophysiologjcal significance.Biol Chem. 1998; 379:973–986.

    Google Scholar 

  50. Sevinsky JR, Rao LVM, Ruf W. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway.J Cell Biol. 1996;133:293–304.

    CAS  PubMed  Google Scholar 

  51. Mulder AB, Smit JW, Bom VJJ, et al. Association of smooth muscle cell tissue factor with caveolae.Blood. 1996;88:1306–1313.

    CAS  PubMed  Google Scholar 

  52. Bach RR, Moldow CE. Mechanism of tissue factor activation on HL-60 cells.Blood. 1997;89:3270–3276.

    CAS  PubMed  Google Scholar 

  53. Bach RR. Mechanism of tissue factor activation on cells.Blood Coagul Fibrinolysis. 1998;9:S37-S43.

    CAS  PubMed  Google Scholar 

  54. Moons AH, Levi M, Peters RJ. Tissue factor and coronary artery disease.Cardiovasc Res. 2002;53:313–325.

    CAS  PubMed  Google Scholar 

  55. Viles-Gonzalez JF, Badimon JJ. Atherothrombosis: the role of tissue factor.Int J Biochem Cell Biol. 2004;36:25–30.

    CAS  PubMed  Google Scholar 

  56. Osterud B. The role of platelets in decrypting monocyte tissue factor.Semin Hematol. 2001;38:2–5.

    CAS  PubMed  Google Scholar 

  57. Taylor FBJr. Role of tissue factor and factor VIIa in the coagulant and inflammatory response to LD100 Escherichia coli in the baboon.Haemostasis. 1996;26:83–91.

    CAS  PubMed  Google Scholar 

  58. Ruf W, Riewald M. Tissue factor-dependent coagulation protease signaling in acute lung injury.Crit Care Med. 2003;31:S231-S237.

    CAS  PubMed  Google Scholar 

  59. Rickles FR, Patierno S, Fernandez PM. Tissue factor, thrombin, and cancer.Chest. 2003;124:58S-68S.

    CAS  PubMed  Google Scholar 

  60. Fukuda C, Iijima K, Nakamura K. Measuring tissue factor (factor III) activity in plasma.Clin Chem. 1989;35:1897–1900.

    CAS  PubMed  Google Scholar 

  61. Koyama T, Nishida K, Ohdama S, et al. Determination of plasma tissue factor antigen and its clinical significance.Br J Haematol. 1994;87:343–347.

    CAS  PubMed  Google Scholar 

  62. Takahashi H, Sato N, Shibata A. Plasma tissue factor pathway inhibitor in disseminated intravascular coagulation: comparison of its behavior with plasma tissue factor.Thromb Res. 1995;80:339–348.

    CAS  PubMed  Google Scholar 

  63. Wada H, Nakase T, Nakaya R, et al. Elevated plasma tissue factor antigen level in patients with disseminated intravascular coagulation.Am J Hemalol. 1994;45:232–236.

    CAS  Google Scholar 

  64. Asakura H, Kamikubo Y, Goto A, et al. Role of tissue factor in disseminated intravascular coagulation.Thromb Res. 1995:80:217–224.

    CAS  PubMed  Google Scholar 

  65. Lwaleed BA, Bass PS, Chisholm M, Francis JL. Urinary tissue factor in glomerulonephritis: a potential marker of glomerular injury?J Clin Pathol. 1997;50:336–340.

    CAS  PubMed Central  PubMed  Google Scholar 

  66. Misumi K, Ogawa H, Yasue H, et al. Comparison of plasma tissue factor levels in unstable and stable angina pectoris.Am. J Cardiol. 1998;81:22–26.

    CAS  PubMed  Google Scholar 

  67. Lwaleed BA, Bass PS, Francis JL. Urinary tissue factor: a potential marker of disease.J Pathol. 1999; 188:3–8.

    CAS  PubMed  Google Scholar 

  68. Key NS, Slungaard A, Dandelet L, et al. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease.Blood. 1998;91:4216–4223.

    CAS  PubMed  Google Scholar 

  69. Giesen PLA, Ranch U, Bohrmann B, et al. Blood-borne tissue factor: another view of thrombosis.Proc Natl Acad Sci U S A. 1999;96:2311–2315.

    CAS  PubMed Central  PubMed  Google Scholar 

  70. Himber J, Wohlgensinger C, Roux S, et al. Inhibition of tissue factor limits the growth of venous thrombus in the rabbit.J Thromb Haemost. 2003 1:889–895.

    CAS  PubMed  Google Scholar 

  71. Giesen PL, Nemerson Y. Tissue factor on the loose.Semin Thromb Hemost. 2000;26:379–384.

    CAS  PubMed  Google Scholar 

  72. Rauch U, Bonderman D, Bohrmann B, et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor.Blood. 2000;96:170–175.

    CAS  PubMed  Google Scholar 

  73. Rauch U, Nemerson Y. Tissue factor, the blood, and the arterial wall.Trends Cardiovasc Med. 2000;10:139–143.

    CAS  PubMed  Google Scholar 

  74. Himber J, Kling D, Fallen JT, Nemerson Y, Riederer MA. In situ localization of tissue factor in human thrombi.Blood. 2002;99:4249–4250.

    CAS  PubMed  Google Scholar 

  75. Ozcan M, Morton CT, Solovey A, et al. Whole blood tissue factor procoagulant activity remains detectable during severe aplasia following bone marrow and peripheral blood stem cell transplantation.Thromb Haemost. 2001;85:250–255.

    CAS  PubMed  Google Scholar 

  76. Siddiqui FA, Desai H, Amirkhosravi A, Amaya M, Francis JL. The presence and release of tissue factor from human platelets.Platelets. 2002;13:247–253.

    CAS  PubMed  Google Scholar 

  77. Müller I, Klocke A, Alex M, et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets.FASEB J. 2003;17:476–478.

    PubMed  Google Scholar 

  78. Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein.Nature Med. 2003;9:458–462.

    CAS  PubMed  Google Scholar 

  79. Broze GJJr.Tissue factor pathway inhibitor and the current concept of blood coagulation.Blood Coagul Fibrinolysis. 1995;6(suppl 1): S7-S13.

    CAS  PubMed  Google Scholar 

  80. Kondo S, Kisiel W. Regulation of factor VIIa in plasma: evidence that antithrombin III is the sole plasma proteinase inhibitor of human factor VIIa.Thromb Res. 1987;46:325.

    CAS  PubMed  Google Scholar 

  81. Girard TJ, MacPhail LA, Likert KM, Novotny WF, Miletich JP, Broze GJ Jr. Inhibition of factor Vila-tissue factor coagulation activity by a hybrid protein.Science. 1990;248:1421–1424.

    CAS  PubMed  Google Scholar 

  82. Dennis MS, Lazarus RA. Kunitz domain inhibitors of tissue factor- factor VIIa; II: potent and specific inhibitors by competitive phage selection.J Biol Chem. 1994;269:22137–22144.

    CAS  PubMed  Google Scholar 

  83. Stassen JM, Lambeir A-M, Matthysscns G, et al. Characterisation of a novel series of aprotinin-derived anticoagulants; I: in vitro and pharmacological properties.Thromb Haemost. 1995;74:646–654.

    CAS  PubMed  Google Scholar 

  84. Lee GF, Lazarus RA, Kelley RF. Potent bifunctional anticoagulants: Kunitz domain tissue factor fusion proteins.Biochemistry. 1997;36:5607–5611.

    CAS  PubMed  Google Scholar 

  85. Stassens P, Bergum PW, Gansemans Y, et al. Anticoagulant repertoire of the hookworm Ancylostoma caninum.Proc Natl Acad Sci U S A. 1996;93:2149–2154.

    CAS  PubMed Central  PubMed  Google Scholar 

  86. Moons AHM, Peters RJG, Bijsterveld NR, et al. Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplasty.J Am Coll Cardiol. 2003;41:2147–2153.

    CAS  PubMed  Google Scholar 

  87. Taylor FB Jr, Chang A, Ruf W, et al. LethalE. coli septic shock is prevented by blocking tissue factor with monoclonal anti body.Circ Shock. 1991;33:127–134.

    PubMed  Google Scholar 

  88. Jang I-K, Gold HK, Leinbach RC, Fallon JT, Collen D, Wilcox JN. Antithrombotic effect of a monoclonal antibody against tissue factor in a rabbit model of platelet-mediated arterial thrombosis.Arte-rioscler Thromb. 1992;12:948–954.

    CAS  Google Scholar 

  89. Thomas WS, Mori E, Copeland BR, Yu J-Q, Morrissey JH, Del Zoppo GJ. Tissue factor contributes to microvascular defects after focal cerebral ischemia.Stroke. 1993;24:847–854.

    CAS  PubMed  Google Scholar 

  90. Pawashe AB, Golino P, Ambrosio G, et al. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries.Circ Res. 1994;74:56–63.

    CAS  PubMed  Google Scholar 

  91. Valentin S, Reutlingsperger CPM, Nordfang O, Lindhout T. Inhibition of factor X activation at extracellular matrix of fibroblasts during flow conditions: a comparison between tissue factor pathway inhibitor and inactive factor VIIa.Thromb Haemosl. 1995:74:1478–1485.

    CAS  Google Scholar 

  92. Jang Y, Guzman LA, Lincoff AM, et al. Influence of blockade at specific levels of the coagulation cascade on rcstcnosis in a rabbit atherosclerotic femoral artery injury model.Circulation. 1995;92:3041–3050.

    CAS  PubMed  Google Scholar 

  93. Harker LA, Hanson SR, Wilcox JN, Kelly AB. Antithrombotic and antilesion benefits without hemorrhagic risks by inhibiting tissue factor pathway.Haemostasis. 1996;26:76–82.

    CAS  PubMed  Google Scholar 

  94. Taylor FB Jr, Chang AC, Peer G, Li A, Ezban M, Hedner U. Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100.Escherichia coli. Blood. 1998;91:1609–1615.

    CAS  Google Scholar 

  95. Himber J, Kirchhofer D, Riederer M,Tschopp TB, Steiner B, Roux SP. Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor function.Thromb Haemosl. 1997; 78:1142–1149.

    CAS  Google Scholar 

  96. Harker LA. Therapeutic inhibition of thrombin activities, receptors, and production.Hematol Oncol Clin North Am. 1998;12:1211–1230.

    CAS  PubMed  Google Scholar 

  97. Klingler O, Matter H, Schudok M, et al. Design, synthesis, and structure-activity relationship of a new class of amidinophenylurea- based factor VIIa inhibitors.Bioorg Med Chem Lett. 2003;13:1463–1467.

    CAS  PubMed  Google Scholar 

  98. Kohrt JT, Filipski KJ, Rapundalo ST, Cody WL, Edmunds JJ. An efficient synthesis of 2-(3-(4-amidinophenylcarbamoyl)naphthalen- 2-yl)5-((2,2-methylpropyl)carbamoyl)benzoic add: a factor VIIa inhibitor discovered by the Ono Pharmaceutical Company.Tetrahedron Lett. 2000;41:6041–6044.

    CAS  Google Scholar 

  99. Parlow JJ, Case BL, Dice TA, et al. Design, parallel synthesis, and crystal structures of pyrazinonc antithrombotics as selective inhibitors of the tissue factor VIIa complex.J Med Chem. 2003: 46:4050–4062.

    CAS  PubMed  Google Scholar 

  100. Roussel P, Bradley M, Kane P, Bailey C, Arnold R, Cross A. Inhibition of the tissue factor factor VIIa complex-lead optimisation using combinatorial chemistry.Tetrahedron. 1999;55:6219–6230.

    CAS  Google Scholar 

  101. Rottingen J-A,EndenT, Camerer F.,Iversen J-G, Prydz H. Binding of human factor VIIa to tissue factor induces cytosolic Ca2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor.J Biol Chem. 1995;270:4650–4660.

    CAS  PubMed  Google Scholar 

  102. Masuda M, Nakamura S, Murakami T, Komiyama Y, Takahashi H. Association of tissue factor with a gamma chain homodimer of the IgE receptor type I in cultured human monocytes.Eur J Immunol. 1996;26:2529–2532.

    CAS  PubMed  Google Scholar 

  103. Poulsen LK, Jacobsen N, Sorensen BB, et al. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor.J Biol Chem. 1998;273:6228–6232.

    CAS  PubMed  Google Scholar 

  104. Pendurthi UR, Alok D, Rao LV. Binding of factor VIIa to tissue factor induces alterations in gene expression in human fibroblast cells: up-regulation of poly(A) polymerase.Proc Natl Acad Sci U S A. 1997;94:12598–12603.

    CAS  PubMed Central  PubMed  Google Scholar 

  105. Camerer E, Gjernes E, Wiiger M, Pringle S, Prydz H. Binding of factor VIIa to tissue factor on keratinocytes induces gene expression.J Biol Chem. 2000;275:6580–6585.

    CAS  PubMed  Google Scholar 

  106. Ruf W, Dorfleutner A, Riewald M. Specificity of coagulation factor signaling.J Thromb Haemost. 2003;l:1495–1503.

    Google Scholar 

  107. Camerer E, Rottingen JA, Iversen JG, Prydz H. Coagulation factors VII and X induce Ca2+ oscillations in Madin-Darby canine kidney cells only when protcolytically active.J Biol Chem. 1996;271:29034–29042.

    CAS  PubMed  Google Scholar 

  108. Camerer E, Huang W, Coughlin SR. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.Proc Natl Acad Sci U S A. 2000;97:5255–5260.

    CAS  PubMed Central  PubMed  Google Scholar 

  109. Riewald M, Ruf W. Orchestration of coagulation protease signaling by tissue factor.Trends Cardiovasc Med. 2002;12:149–154.

    CAS  PubMed  Google Scholar 

  110. Ruf W, Mueller BM. Tissue factor in cancer angiogenesis and metastasis.Curr Opin Hematol. 1996;3:379–384.

    CAS  PubMed  Google Scholar 

  111. Versteeg HH, Peppelenbosch MP, Spek CA. Tissue factor signal transduction in angiogenesis.Carcinogenesis. 2003;24:1009–1013.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Biochemistry Department, University of Illinois at Urbana- Champaign, 417 Med Sci Bidg MC-714,506 S Mathews, Urbana, Illinois, USA

    James H. Morrissey

Authors
  1. James H. Morrissey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James H. Morrissey.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Morrissey, J.H. Tissue factor: A key molecule in hemostatic and nonhemostatic systems. Int J Hematol 79, 103–108 (2004). https://doi.org/10.1532/IJH97.03167

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1532/IJH97.03167

Key worth

Search

Navigation